세계의 펜니들 시장 : 유형(표준, 안전), 바늘 길이, 용도(일회용, 재사용), 용도(인슐린, 성장호르몬, GLP-1), 유통 채널(병원 약국, 소매, 온라인), 사용 환경(재택의료, 병원)별 - 예측(-2031년)

Pen Needles Market by Type (Standard, Safety), Needle Length, Usability (Disposable, Reuse), Application (Insulin, Growth Hormone, GLP-1), Distribution Channel (Hospital Pharmacy, Retail, Online), Setting (Home Care, Hospital)-Global Forecast to 2031

The pen needles market is projected to reach $12.88 billion by 2031 at a CAGR of 9.9% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the rising prevalence of diabetes, growing demand for self-administration of drugs, advancements in technology, and rising healthcare expenditure. However, the needlestick injury concerns restrain the growth of this market.

Furthermore, the rising preference for pen needles over vials and syringes, emerging economies, favorable reimbursement scenarios, and implementation of AI in pen injectors are expected to generate growth opportunities for the players operating in this market. However, the reuse of pen needles, limited access to healthcare in developing nations, and lack of awareness about proper pen needle usage are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the pen needles market are Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), B. Braun Melsungen AG (Germany), Terumo Group (Japan), Allison Medical, Inc. (U.S.), Cardinal Health, Inc. (U.S.), UltiMed, Inc. (U.S.), Hindustan Syringes & Medical Devices Ltd (India), and Nanchang YiLi Medical Instrument Co., LTD (China).

Among all the types studied in this report, in 2024, the safety pen needles segment is expected to account for the largest share of the pen needles market. This segment's large share is driven by the benefits offered by safety pen needles, such as reducing the risk of needlestick injuries. Moreover, companies in the pen needles market are actively enhancing their product portfolios through the introduction of new products and obtaining regulatory approvals.

Among all the needle lengths studied in this report, in 2024, the 4 mm segment is expected to account for the larger share of the pen needles market. 4 mm needles have gained popularity as they reduce discomfort and pain associated with insulin injections. Patients find them less uncomfortable than longer needles, which improves adherence to insulin treatment. Therefore, patients who require regular injections often prefer shorter needles, contributing to the significant market share of this segment.

Among all the usabilities studied in this report, in 2024, the single-use/disposable segment is expected to account for the largest share of the pen needles market. Insulin pen needles are intended for single use only, offering several advantages over traditional syringes. Single-use pen needles provide improved dosing accuracy, ease of use, and reduced pain during injections. Additionally, they help to minimize the risk of infections due to their pre-sterilized nature, eliminating the need for cleaning or sterilization before each use, thereby contributing to the increased adoption of single-use/disposable pen needles.

Among all the applications studied in this report, in 2024, the insulin therapy segment is expected to account for the largest share of the pen needles market. This segment's large market share can be attributed to the rising prevalence of diabetes and the increasing awareness among diabetic patients about self-administration of insulin therapy. Furthermore, recent advancements in insulin therapy, such as ultra-long-acting basal insulin and ultra-rapid-acting insulin therapies, provide greater flexibility in the timing of dosing.

Among all the distribution channels studied in this report, in 2024, the retail pharmacies segment is expected to account for the largest share of the pen needles market. This segment's large market share can be attributed to the increasing consumer demand for pen needles and the opportunity for customers to inspect the product before making a purchase.

Among all the end users studied in this report, in 2024, the home care segment is expected to account for the largest share of the pen needles market. This segment's large market share is driven by several factors, including the growing preference among patients for self-administration of medications, technological advancements in pen needles, and the rising number of diabetes cases worldwide.

An in-depth analysis of the geographical scenario of the pen needles market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the pen needles market. In the region in 2024, the U.S. is expected to account for the largest share of the pen needles market in North America. The large share of this regional market is attributed to the presence of major pen needles companies, such as Becton, Dickinson and Company (U.S.) and Cardinal Health, Inc. (U.S.), the high adoption of pen needles devices in home care, and technological advancements in pen needles in the region.

Scope of the Report:

Pen Needles Market Assessment-by Type

• Standard Pen Needles
• Safety Pen Needles

Pen Needles Market Assessment-by Needle Length

• 4 mm
• 5 mm
• 6 mm
• 8 mm
• 10 mm
• 12 mm & Above

Pen Needles Market Assessment-by Usability

• Single-use/Disposable
• Reusable

Pen Needles Market Assessment-by Application

• Insulin Therapy
• Growth Hormone Therapy
• GLP-1 Therapy
• Other Applications

Note: Other Applications include Osteoporosis, psoriasis, multiple sclerosis, and rheumatoid arthritis.

Pen Needles Market Assessment-by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Pen Needles Market Assessment-by Healthcare Setting

• Home Care
• Hospitals & Clinics
• Other Healthcare Settings

Note: Other Healthcare Settings include nursing care centers, long-term care settings, and ambulatory care centers.

Pen Needles Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Spain
  • Austria
  • Netherlands
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition and Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Increasing Prevalence of Diabetes
  • 4.2.2. Technological Advancements
  • 4.2.3. Increasing Demand for Self-Admiration of Drugs
  • 4.2.4. Rising Healthcare Expenditure
• 4.3. Restraints
  • 4.3.1. Needlestick Injury Concerns
• 4.4. Opportunities
  • 4.4.1. Rising Preference for Pen Needles over Vials and Syringes
  • 4.4.2. Emerging Economies
  • 4.4.3. Favourable Reimbursement Scenario
  • 4.4.4. Implementation of AI in Pen Injectors
• 4.5. Challenges
  • 4.5.1. Reuse of Pen Needles
  • 4.5.2. Limited Access to Healthcare in Developing Countries
  • 4.5.3. Lack of Awareness and Knowledge of Pen Needles
• 4.6. Factor Analysis
• 4.7. Industry Trends
• 4.8. Pricing Analysis
• 4.9. Regulatory Analysis
• 4.10. Porter's Five Forces Analysis
• 4.11. Parent/Adjacent Market Analysis

5. Pen Needles Market Assessment-by Type

• 5.1. Overview
• 5.2. Standard Needles
• 5.3. Safety Needles

6. Pen Needles Market Assessment-by Needle Length

• 6.1. Overview
• 6.2. 4 mm
• 6.3. 5 mm
• 6.4. 6 mm
• 6.5. 8 mm
• 6.6. 10 mm
• 6.7. 12 mm & Above

7. Pen Needles Market Assessment-by Usability

• 7.1. Overview
• 7.2. Single-use/Disposable Needles
• 7.3. Reusable Needles

8. Pen Needles Market Assessment-by Application

• 8.1. Overview
• 8.2. Insulin Therapy
• 8.3. Growth Hormone Therapy
• 8.4. GLP-1 Therapy
• 8.5. Other Applications

9. Pen Needles Market Assessment-by Distribution Channel

• 9.1. Overview
• 9.2. Hospital Pharmacies
• 9.3. Retail Pharmacies
• 9.4. Online Channels

10. Pen Needles Market Assessment-by Healthcare Setting

• 10.1. Overview
• 10.2. Home Care
• 10.3. Hospitals and Clinics
• 10.4. Other Healthcare Settings

11. Pen Needles Market Assessment-by Geography

• 11.1. Overview
• 11.2. North America
  • 11.2.1. U.S.
  • 11.2.2. Canada
• 11.3. Europe
  • 11.3.1. Germany
  • 11.3.2. France
  • 11.3.3. U.K.
  • 11.3.4. Italy
  • 11.3.5. Spain
  • 11.3.6. Austria
  • 11.3.7. Netherlands
  • 11.3.8. Rest of Europe
• 11.4. Asia-Pacific
  • 11.4.1. Japan
  • 11.4.2. China
  • 11.4.3. India
  • 11.4.4. South Korea
  • 11.4.5. Australia
  • 11.4.6. Rest of Asia-Pacific
• 11.5. Latin America
  • 11.5.1. Brazil
  • 11.5.2. Mexico
  • 11.5.3. Rest of Latin America
• 11.6. Middle East & Africa

12. Competition Analysis

• 12.1. Overview
• 12.2. Key Growth Strategies
• 12.3. Competitive Benchmarking
• 12.4. Competitive Dashboard
  • 12.4.1. Industry Leaders
  • 12.4.2. Market Differentiators
  • 12.4.3. Vanguards
  • 12.4.4. Emerging Companies
• 12.5. Market Share Analysis/Market Rankings, by Key Players (2023)

13. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

• 13.1. Becton, Dickinson and Company
• 13.2. Novo Nordisk A/S
• 13.3. Ypsomed AG
• 13.4. Owen Mumford Limited
• 13.5. B. Braun Melsungen AG
• 13.6. Terumo Group
• 13.7. Allison Medical, Inc.
• 13.8. Cardinal Health, Inc.
• 13.9. Trividia Health, Inc.
• 13.10. UltiMed, Inc.
• 13.11. Hindustan Syringes & Medical Devices Ltd
• 13.12. Nanchang YiLi Medical Instrument Co.,LTD

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

14. Appendix

• 14.1. Available Customization
• 14.2. Related Reports